5-bromo-3-tert-butyl-2-methylpyrazine;3-tert-butyl-N-cyclopropylpyrazin-2-amine;3-tert-butyl-2,5-dimethylpyrazine;2-tert-butyl-3-ethylpyrazine;3-tert-butylimidazo[1,2-b]pyridazine;3-tert-butyl-2-methylimidazo[1,2-b]pyridazine;bis(2-tert-butyl-3-methylpyrazine);2-tert-butyl-3-methylpyridine;3-tert-butyl-2-methylpyridine;5-tert-butyl-4-methylpyrimidine;5-tert-butyl-2-methyl-1,3-thiazole;2-tert-butylpyrazine;3-tert-butylpyrazine-2-carboxamide;4-tert-butyl-1H-pyrazol-5-amine;6-tert-butylpyridin-2-amine;3-tert-butylpyridine;4-(5-tert-butylpyrimidin-4-yl)morpholine;3-tert-butyl-1H-pyrrole;3-tert-butyl-2-(1H-pyrrol-3-yl)pyridine;N-(5-tert-butyl-1,3-thiazol-2-yl)acetamide

C200H302BrN43O3S2 — CID 161126539

IUPAC5-bromo-3-tert-butyl-2-methylpyrazine;3-tert-butyl-N-cyclopropylpyrazin-2-amine;3-tert-butyl-2,5-dimethylpyrazine;2-tert-butyl-3-ethylpyrazine;3-tert-butylimidazo[1,2-b]pyridazine;3-tert-butyl-2-methylimidazo[1,2-b]pyridazine;bis(2-tert-butyl-3-methylpyrazine);2-tert-butyl-3-methylpyridine;3-tert-butyl-2-methylpyridine;5-tert-butyl-4-methylpyrimidine;5-tert-butyl-2-methyl-1,3-thiazole;2-tert-butylpyrazine;3-tert-butylpyrazine-2-carboxamide;4-tert-butyl-1H-pyrazol-5-amine;6-tert-butylpyridin-2-amine;3-tert-butylpyridine;4-(5-tert-butylpyrimidin-4-yl)morpholine;3-tert-butyl-1H-pyrrole;3-tert-butyl-2-(1H-pyrrol-3-yl)pyridine;N-(5-tert-butyl-1,3-thiazol-2-yl)acetamide
SMILESCC(=O)Nc1ncc(C(C)(C)C)s1.CC(C)(C)c1cc[nH]c1.CC(C)(C)c1cccc(N)n1.CC(C)(C)c1cccnc1.CC(C)(C)c1cccnc1-c1cc[nH]c1.CC(C)(C)c1cn[nH]c1N.CC(C)(C)c1cnc2cccnn12.CC(C)(C)c1cnccn1.CC(C)(C)c1cncnc1N1CCOCC1.CC(C)(C)c1nccnc1C(N)=O.CC(C)(C)c1nccnc1NC1CC1.CCc1nccnc1C(C)(C)C.Cc1cccnc1C(C)(C)C.Cc1cnc(C)c(C(C)(C)C)n1.Cc1nc2cccnn2c1C(C)(C)C.Cc1ncc(Br)nc1C(C)(C)C.Cc1ncc(C(C)(C)C)s1.Cc1ncccc1C(C)(C)C.Cc1nccnc1C(C)(C)C.Cc1nccnc1C(C)(C)C.Cc1ncncc1C(C)(C)C
InChIInChI=1S/C13H16N2.C12H19N3O.C11H15N3.C11H17N3.C10H13N3.2C10H16N2.2C10H15N.C9H13BrN2.C9H13N3O.C9H14N2OS.4C9H14N2.C9H13N.C8H12N2.C8H13NS.C8H13N.C7H13N3/c1-13(2,3)11-5-4-7-15-12(11)10-6-8-14-9-10;1-12(2,3)10-8-13-9-14-11(10)15-4-6-16-7-5-15;1-8-10(11(2,3)4)14-9(13-8)6-5-7-12-14;1-11(2,3)9-10(13-7-6-12-9)14-8-4-5-8;1-10(2,3)8-7-11-9-5-4-6-12-13(8)9;1-7-6-11-8(2)9(12-7)10(3,4)5;1-5-8-9(10(2,3)4)12-7-6-11-8;1-8-9(10(2,3)4)6-5-7-11-8;1-8-6-5-7-11-9(8)10(2,3)4;1-6-8(9(2,3)4)12-7(10)5-11-6;1-9(2,3)7-6(8(10)13)11-4-5-12-7;1-6(12)11-8-10-5-7(13-8)9(2,3)4;1-7-8(9(2,3)4)5-10-6-11-7;2*1-7-8(9(2,3)4)11-6-5-10-7;1-9(2,3)7-5-4-6-8(10)11-7;1-9(2,3)8-5-4-6-10-7-8;1-8(2,3)7-6-9-4-5-10-7;1-6-9-5-7(10-6)8(2,3)4;1-8(2,3)7-4-5-9-6-7;1-7(2,3)5-4-9-10-6(5)8/h4-9,14H,1-3H3;8-9H,4-7H2,1-3H3;5-7H,1-4H3;6-8H,4-5H2,1-3H3,(H,13,14);4-7H,1-3H3;6H,1-5H3;6-7H,5H2,1-4H3;2*5-7H,1-4H3;5H,1-4H3;4-5H,1-3H3,(H2,10,13);5H,1-4H3,(H,10,11,12);3*5-6H,1-4H3;4-6H,1-3H3,(H2,10,11);4-7H,1-3H3;4-6H,1-3H3;5H,1-4H3;4-6,9H,1-3H3;4H,1-3H3,(H3,8,9,10)
InChIKeyULQARQFCEGQCQR-UHFFFAOYSA-N
MW3500.95 g/mol
LogP46.63
Rot. Bonds7

About 5-bromo-3-tert-butyl-2-methylpyrazine;3-tert-butyl-N-cyclopropylpyrazin-2-amine;3-tert-butyl-2,5-dimethylpyrazine;2-tert-butyl-3-ethylpyrazine;3-tert-butylimidazo[1,2-b]pyridazine;3-tert-butyl-2-methylimidazo[1,2-b]pyridazine;bis(2-tert-butyl-3-methylpyrazine);2-tert-butyl-3-methylpyridine;3-tert-butyl-2-methylpyridine;5-tert-butyl-4-methylpyrimidine;5-tert-butyl-2-methyl-1,3-thiazole;2-tert-butylpyrazine;3-tert-butylpyrazine-2-carboxamide;4-tert-butyl-1H-pyrazol-5-amine;6-tert-butylpyridin-2-amine;3-tert-butylpyridine;4-(5-tert-butylpyrimidin-4-yl)morpholine;3-tert-butyl-1H-pyrrole;3-tert-butyl-2-(1H-pyrrol-3-yl)pyridine;N-(5-tert-butyl-1,3-thiazol-2-yl)acetamide

5-bromo-3-tert-butyl-2-methylpyrazine;3-tert-butyl-N-cyclopropylpyrazin-2-amine;3-tert-butyl-2,5-dimethylpyrazine;2-tert-butyl-3-ethylpyrazine;3-tert-butylimidazo[1,2-b]pyridazine;3-tert-butyl-2-methylimidazo[1,2-b]pyridazine;bis(2-tert-butyl-3-methylpyrazine);2-tert-butyl-3-methylpyridine;3-tert-butyl-2-methylpyridine;5-tert-butyl-4-methylpyrimidine;5-tert-butyl-2-methyl-1,3-thiazole;2-tert-butylpyrazine;3-tert-butylpyrazine-2-carboxamide;4-tert-butyl-1H-pyrazol-5-amine;6-tert-butylpyridin-2-amine;3-tert-butylpyridine;4-(5-tert-butylpyrimidin-4-yl)morpholine;3-tert-butyl-1H-pyrrole;3-tert-butyl-2-(1H-pyrrol-3-yl)pyridine;N-(5-tert-butyl-1,3-thiazol-2-yl)acetamide (PubChem CID 161126539) has the molecular formula C200H302BrN43O3S2 and a molecular weight of 3500.95 g/mol. Its IUPAC name is 5-bromo-3-tert-butyl-2-methylpyrazine;3-tert-butyl-N-cyclopropylpyrazin-2-amine;3-tert-butyl-2,5-dimethylpyrazine;2-tert-butyl-3-ethylpyrazine;3-tert-butylimidazo[1,2-b]pyridazine;3-tert-butyl-2-methylimidazo[1,2-b]pyridazine;bis(2-tert-butyl-3-methylpyrazine);2-tert-butyl-3-methylpyridine;3-tert-butyl-2-methylpyridine;5-tert-butyl-4-methylpyrimidine;5-tert-butyl-2-methyl-1,3-thiazole;2-tert-butylpyrazine;3-tert-butylpyrazine-2-carboxamide;4-tert-butyl-1H-pyrazol-5-amine;6-tert-butylpyridin-2-amine;3-tert-butylpyridine;4-(5-tert-butylpyrimidin-4-yl)morpholine;3-tert-butyl-1H-pyrrole;3-tert-butyl-2-(1H-pyrrol-3-yl)pyridine;N-(5-tert-butyl-1,3-thiazol-2-yl)acetamide.

Molecular Properties

Compound Name5-bromo-3-tert-butyl-2-methylpyrazine;3-tert-butyl-N-cyclopropylpyrazin-2-amine;3-tert-butyl-2,5-dimethylpyrazine;2-tert-butyl-3-ethylpyrazine;3-tert-butylimidazo[1,2-b]pyridazine;3-tert-butyl-2-methylimidazo[1,2-b]pyridazine;bis(2-tert-butyl-3-methylpyrazine);2-tert-butyl-3-methylpyridine;3-tert-butyl-2-methylpyridine;5-tert-butyl-4-methylpyrimidine;5-tert-butyl-2-methyl-1,3-thiazole;2-tert-butylpyrazine;3-tert-butylpyrazine-2-carboxamide;4-tert-butyl-1H-pyrazol-5-amine;6-tert-butylpyridin-2-amine;3-tert-butylpyridine;4-(5-tert-butylpyrimidin-4-yl)morpholine;3-tert-butyl-1H-pyrrole;3-tert-butyl-2-(1H-pyrrol-3-yl)pyridine;N-(5-tert-butyl-1,3-thiazol-2-yl)acetamide
PubChem CID161126539
Molecular FormulaC200H302BrN43O3S2
Molecular Weight3500.95 g/mol
Exact Mass3497.34
IUPAC Name5-bromo-3-tert-butyl-2-methylpyrazine;3-tert-butyl-N-cyclopropylpyrazin-2-amine;3-tert-butyl-2,5-dimethylpyrazine;2-tert-butyl-3-ethylpyrazine;3-tert-butylimidazo[1,2-b]pyridazine;3-tert-butyl-2-methylimidazo[1,2-b]pyridazine;bis(2-tert-butyl-3-methylpyrazine);2-tert-butyl-3-methylpyridine;3-tert-butyl-2-methylpyridine;5-tert-butyl-4-methylpyrimidine;5-tert-butyl-2-methyl-1,3-thiazole;2-tert-butylpyrazine;3-tert-butylpyrazine-2-carboxamide;4-tert-butyl-1H-pyrazol-5-amine;6-tert-butylpyridin-2-amine;3-tert-butylpyridine;4-(5-tert-butylpyrimidin-4-yl)morpholine;3-tert-butyl-1H-pyrrole;3-tert-butyl-2-(1H-pyrrol-3-yl)pyridine;N-(5-tert-butyl-1,3-thiazol-2-yl)acetamide
SMILESCC(=O)Nc1ncc(C(C)(C)C)s1.CC(C)(C)c1cc[nH]c1.CC(C)(C)c1cccc(N)n1.CC(C)(C)c1cccnc1.CC(C)(C)c1cccnc1-c1cc[nH]c1.CC(C)(C)c1cn[nH]c1N.CC(C)(C)c1cnc2cccnn12.CC(C)(C)c1cnccn1.CC(C)(C)c1cncnc1N1CCOCC1.CC(C)(C)c1nccnc1C(N)=O.CC(C)(C)c1nccnc1NC1CC1.CCc1nccnc1C(C)(C)C.Cc1cccnc1C(C)(C)C.Cc1cnc(C)c(C(C)(C)C)n1.Cc1nc2cccnn2c1C(C)(C)C.Cc1ncc(Br)nc1C(C)(C)C.Cc1ncc(C(C)(C)C)s1.Cc1ncccc1C(C)(C)C.Cc1nccnc1C(C)(C)C.Cc1nccnc1C(C)(C)C.Cc1ncncc1C(C)(C)C
InChIInChI=1S/C13H16N2.C12H19N3O.C11H15N3.C11H17N3.C10H13N3.2C10H16N2.2C10H15N.C9H13BrN2.C9H13N3O.C9H14N2OS.4C9H14N2.C9H13N.C8H12N2.C8H13NS.C8H13N.C7H13N3/c1-13(2,3)11-5-4-7-15-12(11)10-6-8-14-9-10;1-12(2,3)10-8-13-9-14-11(10)15-4-6-16-7-5-15;1-8-10(11(2,3)4)14-9(13-8)6-5-7-12-14;1-11(2,3)9-10(13-7-6-12-9)14-8-4-5-8;1-10(2,3)8-7-11-9-5-4-6-12-13(8)9;1-7-6-11-8(2)9(12-7)10(3,4)5;1-5-8-9(10(2,3)4)12-7-6-11-8;1-8-9(10(2,3)4)6-5-7-11-8;1-8-6-5-7-11-9(8)10(2,3)4;1-6-8(9(2,3)4)12-7(10)5-11-6;1-9(2,3)7-6(8(10)13)11-4-5-12-7;1-6(12)11-8-10-5-7(13-8)9(2,3)4;1-7-8(9(2,3)4)5-10-6-11-7;2*1-7-8(9(2,3)4)11-6-5-10-7;1-9(2,3)7-5-4-6-8(10)11-7;1-9(2,3)8-5-4-6-10-7-8;1-8(2,3)7-6-9-4-5-10-7;1-6-9-5-7(10-6)8(2,3)4;1-8(2,3)7-4-5-9-6-7;1-7(2,3)5-4-9-10-6(5)8/h4-9,14H,1-3H3;8-9H,4-7H2,1-3H3;5-7H,1-4H3;6-8H,4-5H2,1-3H3,(H,13,14);4-7H,1-3H3;6H,1-5H3;6-7H,5H2,1-4H3;2*5-7H,1-4H3;5H,1-4H3;4-5H,1-3H3,(H2,10,13);5H,1-4H3,(H,10,11,12);3*5-6H,1-4H3;4-6H,1-3H3,(H2,10,11);4-7H,1-3H3;4-6H,1-3H3;5H,1-4H3;4-6,9H,1-3H3;4H,1-3H3,(H3,8,9,10)
InChIKeyULQARQFCEGQCQR-UHFFFAOYSA-N
XLogP46.63
TPSA617.40 Ų
H-Bond Donors8
H-Bond Acceptors43
Rotatable Bonds7
Heavy Atoms249
Complexity

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5003500.95
LogP ≤ 546.63
H-Bond Donors ≤ 58
H-Bond Acceptors ≤ 1043

Analyze 5-bromo-3-tert-butyl-2-methylpyrazine;3-tert-butyl-N-cyclopropylpyrazin-2-amine;3-tert-butyl-2,5-dimethylpyrazine;2-tert-butyl-3-ethylpyrazine;3-tert-butylimidazo[1,2-b]pyridazine;3-tert-butyl-2-methylimidazo[1,2-b]pyridazine;bis(2-tert-butyl-3-methylpyrazine);2-tert-butyl-3-methylpyridine;3-tert-butyl-2-methylpyridine;5-tert-butyl-4-methylpyrimidine;5-tert-butyl-2-methyl-1,3-thiazole;2-tert-butylpyrazine;3-tert-butylpyrazine-2-carboxamide;4-tert-butyl-1H-pyrazol-5-amine;6-tert-butylpyridin-2-amine;3-tert-butylpyridine;4-(5-tert-butylpyrimidin-4-yl)morpholine;3-tert-butyl-1H-pyrrole;3-tert-butyl-2-(1H-pyrrol-3-yl)pyridine;N-(5-tert-butyl-1,3-thiazol-2-yl)acetamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 5-bromo-3-tert-butyl-2-methylpyrazine;3-tert-butyl-N-cyclopropylpyrazin-2-amine;3-tert-butyl-2,5-dimethylpyrazine;2-tert-butyl-3-ethylpyrazine;3-tert-butylimidazo[1,2-b]pyridazine;3-tert-butyl-2-methylimidazo[1,2-b]pyridazine;bis(2-tert-butyl-3-methylpyrazine);2-tert-butyl-3-methylpyridine;3-tert-butyl-2-methylpyridine;5-tert-butyl-4-methylpyrimidine;5-tert-butyl-2-methyl-1,3-thiazole;2-tert-butylpyrazine;3-tert-butylpyrazine-2-carboxamide;4-tert-butyl-1H-pyrazol-5-amine;6-tert-butylpyridin-2-amine;3-tert-butylpyridine;4-(5-tert-butylpyrimidin-4-yl)morpholine;3-tert-butyl-1H-pyrrole;3-tert-butyl-2-(1H-pyrrol-3-yl)pyridine;N-(5-tert-butyl-1,3-thiazol-2-yl)acetamide?
The IUPAC name of 5-bromo-3-tert-butyl-2-methylpyrazine;3-tert-butyl-N-cyclopropylpyrazin-2-amine;3-tert-butyl-2,5-dimethylpyrazine;2-tert-butyl-3-ethylpyrazine;3-tert-butylimidazo[1,2-b]pyridazine;3-tert-butyl-2-methylimidazo[1,2-b]pyridazine;bis(2-tert-butyl-3-methylpyrazine);2-tert-butyl-3-methylpyridine;3-tert-butyl-2-methylpyridine;5-tert-butyl-4-methylpyrimidine;5-tert-butyl-2-methyl-1,3-thiazole;2-tert-butylpyrazine;3-tert-butylpyrazine-2-carboxamide;4-tert-butyl-1H-pyrazol-5-amine;6-tert-butylpyridin-2-amine;3-tert-butylpyridine;4-(5-tert-butylpyrimidin-4-yl)morpholine;3-tert-butyl-1H-pyrrole;3-tert-butyl-2-(1H-pyrrol-3-yl)pyridine;N-(5-tert-butyl-1,3-thiazol-2-yl)acetamide (CID 161126539) is 5-bromo-3-tert-butyl-2-methylpyrazine;3-tert-butyl-N-cyclopropylpyrazin-2-amine;3-tert-butyl-2,5-dimethylpyrazine;2-tert-butyl-3-ethylpyrazine;3-tert-butylimidazo[1,2-b]pyridazine;3-tert-butyl-2-methylimidazo[1,2-b]pyridazine;bis(2-tert-butyl-3-methylpyrazine);2-tert-butyl-3-methylpyridine;3-tert-butyl-2-methylpyridine;5-tert-butyl-4-methylpyrimidine;5-tert-butyl-2-methyl-1,3-thiazole;2-tert-butylpyrazine;3-tert-butylpyrazine-2-carboxamide;4-tert-butyl-1H-pyrazol-5-amine;6-tert-butylpyridin-2-amine;3-tert-butylpyridine;4-(5-tert-butylpyrimidin-4-yl)morpholine;3-tert-butyl-1H-pyrrole;3-tert-butyl-2-(1H-pyrrol-3-yl)pyridine;N-(5-tert-butyl-1,3-thiazol-2-yl)acetamide.
What is the SMILES notation for 5-bromo-3-tert-butyl-2-methylpyrazine;3-tert-butyl-N-cyclopropylpyrazin-2-amine;3-tert-butyl-2,5-dimethylpyrazine;2-tert-butyl-3-ethylpyrazine;3-tert-butylimidazo[1,2-b]pyridazine;3-tert-butyl-2-methylimidazo[1,2-b]pyridazine;bis(2-tert-butyl-3-methylpyrazine);2-tert-butyl-3-methylpyridine;3-tert-butyl-2-methylpyridine;5-tert-butyl-4-methylpyrimidine;5-tert-butyl-2-methyl-1,3-thiazole;2-tert-butylpyrazine;3-tert-butylpyrazine-2-carboxamide;4-tert-butyl-1H-pyrazol-5-amine;6-tert-butylpyridin-2-amine;3-tert-butylpyridine;4-(5-tert-butylpyrimidin-4-yl)morpholine;3-tert-butyl-1H-pyrrole;3-tert-butyl-2-(1H-pyrrol-3-yl)pyridine;N-(5-tert-butyl-1,3-thiazol-2-yl)acetamide?
The canonical SMILES for 5-bromo-3-tert-butyl-2-methylpyrazine;3-tert-butyl-N-cyclopropylpyrazin-2-amine;3-tert-butyl-2,5-dimethylpyrazine;2-tert-butyl-3-ethylpyrazine;3-tert-butylimidazo[1,2-b]pyridazine;3-tert-butyl-2-methylimidazo[1,2-b]pyridazine;bis(2-tert-butyl-3-methylpyrazine);2-tert-butyl-3-methylpyridine;3-tert-butyl-2-methylpyridine;5-tert-butyl-4-methylpyrimidine;5-tert-butyl-2-methyl-1,3-thiazole;2-tert-butylpyrazine;3-tert-butylpyrazine-2-carboxamide;4-tert-butyl-1H-pyrazol-5-amine;6-tert-butylpyridin-2-amine;3-tert-butylpyridine;4-(5-tert-butylpyrimidin-4-yl)morpholine;3-tert-butyl-1H-pyrrole;3-tert-butyl-2-(1H-pyrrol-3-yl)pyridine;N-(5-tert-butyl-1,3-thiazol-2-yl)acetamide is CC(=O)Nc1ncc(C(C)(C)C)s1.CC(C)(C)c1cc[nH]c1.CC(C)(C)c1cccc(N)n1.CC(C)(C)c1cccnc1.CC(C)(C)c1cccnc1-c1cc[nH]c1.CC(C)(C)c1cn[nH]c1N.CC(C)(C)c1cnc2cccnn12.CC(C)(C)c1cnccn1.CC(C)(C)c1cncnc1N1CCOCC1.CC(C)(C)c1nccnc1C(N)=O.CC(C)(C)c1nccnc1NC1CC1.CCc1nccnc1C(C)(C)C.Cc1cccnc1C(C)(C)C.Cc1cnc(C)c(C(C)(C)C)n1.Cc1nc2cccnn2c1C(C)(C)C.Cc1ncc(Br)nc1C(C)(C)C.Cc1ncc(C(C)(C)C)s1.Cc1ncccc1C(C)(C)C.Cc1nccnc1C(C)(C)C.Cc1nccnc1C(C)(C)C.Cc1ncncc1C(C)(C)C.
What is the InChIKey of 5-bromo-3-tert-butyl-2-methylpyrazine;3-tert-butyl-N-cyclopropylpyrazin-2-amine;3-tert-butyl-2,5-dimethylpyrazine;2-tert-butyl-3-ethylpyrazine;3-tert-butylimidazo[1,2-b]pyridazine;3-tert-butyl-2-methylimidazo[1,2-b]pyridazine;bis(2-tert-butyl-3-methylpyrazine);2-tert-butyl-3-methylpyridine;3-tert-butyl-2-methylpyridine;5-tert-butyl-4-methylpyrimidine;5-tert-butyl-2-methyl-1,3-thiazole;2-tert-butylpyrazine;3-tert-butylpyrazine-2-carboxamide;4-tert-butyl-1H-pyrazol-5-amine;6-tert-butylpyridin-2-amine;3-tert-butylpyridine;4-(5-tert-butylpyrimidin-4-yl)morpholine;3-tert-butyl-1H-pyrrole;3-tert-butyl-2-(1H-pyrrol-3-yl)pyridine;N-(5-tert-butyl-1,3-thiazol-2-yl)acetamide?
The InChIKey is ULQARQFCEGQCQR-UHFFFAOYSA-N. The full InChI is InChI=1S/C13H16N2.C12H19N3O.C11H15N3.C11H17N3.C10H13N3.2C10H16N2.2C10H15N.C9H13BrN2.C9H13N3O.C9H14N2OS.4C9H14N2.C9H13N.C8H12N2.C8H13NS.C8H13N.C7H13N3/c1-13(2,3)11-5-4-7-15-12(11)10-6-8-14-9-10;1-12(2,3)10-8-13-9-14-11(10)15-4-6-16-7-5-15;1-8-10(11(2,3)4)14-9(13-8)6-5-7-12-14;1-11(2,3)9-10(13-7-6-12-9)14-8-4-5-8;1-10(2,3)8-7-11-9-5-4-6-12-13(8)9;1-7-6-11-8(2)9(12-7)10(3,4)5;1-5-8-9(10(2,3)4)12-7-6-11-8;1-8-9(10(2,3)4)6-5-7-11-8;1-8-6-5-7-11-9(8)10(2,3)4;1-6-8(9(2,3)4)12-7(10)5-11-6;1-9(2,3)7-6(8(10)13)11-4-5-12-7;1-6(12)11-8-10-5-7(13-8)9(2,3)4;1-7-8(9(2,3)4)5-10-6-11-7;2*1-7-8(9(2,3)4)11-6-5-10-7;1-9(2,3)7-5-4-6-8(10)11-7;1-9(2,3)8-5-4-6-10-7-8;1-8(2,3)7-6-9-4-5-10-7;1-6-9-5-7(10-6)8(2,3)4;1-8(2,3)7-4-5-9-6-7;1-7(2,3)5-4-9-10-6(5)8/h4-9,14H,1-3H3;8-9H,4-7H2,1-3H3;5-7H,1-4H3;6-8H,4-5H2,1-3H3,(H,13,14);4-7H,1-3H3;6H,1-5H3;6-7H,5H2,1-4H3;2*5-7H,1-4H3;5H,1-4H3;4-5H,1-3H3,(H2,10,13);5H,1-4H3,(H,10,11,12);3*5-6H,1-4H3;4-6H,1-3H3,(H2,10,11);4-7H,1-3H3;4-6H,1-3H3;5H,1-4H3;4-6,9H,1-3H3;4H,1-3H3,(H3,8,9,10).
What are the key properties of 5-bromo-3-tert-butyl-2-methylpyrazine;3-tert-butyl-N-cyclopropylpyrazin-2-amine;3-tert-butyl-2,5-dimethylpyrazine;2-tert-butyl-3-ethylpyrazine;3-tert-butylimidazo[1,2-b]pyridazine;3-tert-butyl-2-methylimidazo[1,2-b]pyridazine;bis(2-tert-butyl-3-methylpyrazine);2-tert-butyl-3-methylpyridine;3-tert-butyl-2-methylpyridine;5-tert-butyl-4-methylpyrimidine;5-tert-butyl-2-methyl-1,3-thiazole;2-tert-butylpyrazine;3-tert-butylpyrazine-2-carboxamide;4-tert-butyl-1H-pyrazol-5-amine;6-tert-butylpyridin-2-amine;3-tert-butylpyridine;4-(5-tert-butylpyrimidin-4-yl)morpholine;3-tert-butyl-1H-pyrrole;3-tert-butyl-2-(1H-pyrrol-3-yl)pyridine;N-(5-tert-butyl-1,3-thiazol-2-yl)acetamide?
5-bromo-3-tert-butyl-2-methylpyrazine;3-tert-butyl-N-cyclopropylpyrazin-2-amine;3-tert-butyl-2,5-dimethylpyrazine;2-tert-butyl-3-ethylpyrazine;3-tert-butylimidazo[1,2-b]pyridazine;3-tert-butyl-2-methylimidazo[1,2-b]pyridazine;bis(2-tert-butyl-3-methylpyrazine);2-tert-butyl-3-methylpyridine;3-tert-butyl-2-methylpyridine;5-tert-butyl-4-methylpyrimidine;5-tert-butyl-2-methyl-1,3-thiazole;2-tert-butylpyrazine;3-tert-butylpyrazine-2-carboxamide;4-tert-butyl-1H-pyrazol-5-amine;6-tert-butylpyridin-2-amine;3-tert-butylpyridine;4-(5-tert-butylpyrimidin-4-yl)morpholine;3-tert-butyl-1H-pyrrole;3-tert-butyl-2-(1H-pyrrol-3-yl)pyridine;N-(5-tert-butyl-1,3-thiazol-2-yl)acetamide has a molecular weight of 3500.95 g/mol, XLogP of 46.63, 7 rotatable bonds, 8 hydrogen bond donors, and 43 hydrogen bond acceptors.
Where does this data come from?
All data for 5-bromo-3-tert-butyl-2-methylpyrazine;3-tert-butyl-N-cyclopropylpyrazin-2-amine;3-tert-butyl-2,5-dimethylpyrazine;2-tert-butyl-3-ethylpyrazine;3-tert-butylimidazo[1,2-b]pyridazine;3-tert-butyl-2-methylimidazo[1,2-b]pyridazine;bis(2-tert-butyl-3-methylpyrazine);2-tert-butyl-3-methylpyridine;3-tert-butyl-2-methylpyridine;5-tert-butyl-4-methylpyrimidine;5-tert-butyl-2-methyl-1,3-thiazole;2-tert-butylpyrazine;3-tert-butylpyrazine-2-carboxamide;4-tert-butyl-1H-pyrazol-5-amine;6-tert-butylpyridin-2-amine;3-tert-butylpyridine;4-(5-tert-butylpyrimidin-4-yl)morpholine;3-tert-butyl-1H-pyrrole;3-tert-butyl-2-(1H-pyrrol-3-yl)pyridine;N-(5-tert-butyl-1,3-thiazol-2-yl)acetamide is sourced from PubChem (CID 161126539), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).